Endologix Inc - Strategy, SWOT and Corporate Finance Report

Endologix Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Endologix, Inc. (Endologix) is a medical device company. It undertakes the development, manufacturing and selling of minimally invasive devices in treatment of aortic diseases. The company lays focus on its patented technology for the treatment of Abdominal Aortic Aneurysms (AAA). The company’s AAA products are built on traditional minimally-invasive endovascular repair (EVAR) platform or endovascular sealing (EVAS) platform and Ovation system. The company’s EVAR products include AFX endovascular AAA system. Its Ovation system consists of a low-permeability polytetrafluoroethylene and a radiopaque nitinol suprarenal stent with integral anchors.

Scope

  • Detailed information on Endologix Inc required for business and competitor intelligence needs
  • A study of the major internal and external factors affecting Endologix Inc in the form of a SWOT analysis
  • An in-depth view of the business model of Endologix Inc including a breakdown and examination of key business segments
  • News about Endologix Inc, such as business expansion, restructuring, and contract wins
  • Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

  • Gain understanding of Endologix Inc and the factors that influence its strategies.
  • Track strategic initiatives of the company and latest corporate news and actions.
  • Assess Endologix Inc as a prospective partner, vendor or supplier.
  • Support sales activities by understanding your customers' businesses better.
  • Stay up to date on Endologix Incs business structure, strategy and prospects.

Note: Some sections may be missing if data is unavailable for the company.

Companies mentioned

Aptus Endosystems Inc

Cook Medical Inc

Cordis Corp

Lombard Medical Technologies Ltd

Medtronic Plc

St. Jude Medical LLC

W. L. Gore & Associates Inc

Aptus Endosystems Inc

Cook Medical Inc

Cordis Corp

Lombard Medical Technologies Ltd

Medtronic Plc

St. Jude Medical LLC

W. L. Gore & Associates Inc

Table of Contents

Table of Contents

Table of Contents

List of Tables

List of Figures

Section 1 - About the Company

Endologix Inc - Key Facts

Endologix Inc - Key Employees ...

Table of Contents

Table of Contents

List of Tables

List of Figures

Section 1 - About the Company

Endologix Inc - Key Facts

Endologix Inc - Key Employees

Endologix Inc - Key Employee Biographies

Endologix Inc - Major Products and Services

Endologix Inc - History

Endologix Inc - Company Statement

Endologix Inc - Locations And Subsidiaries

Head Office

Other Locations & Subsidiaries

Section 2 – Company Analysis

Company Overview

Endologix Inc - Business Description

R&D Overview

Endologix Inc - Corporate Strategy

Endologix Inc - SWOT Analysis

SWOT Analysis - Overview

Endologix Inc - Strengths

Endologix Inc - Weaknesses

Endologix Inc - Opportunities

Endologix Inc - Threats

Endologix Inc - Key Competitors

Section 3 – Company Financial Ratios

Financial Ratios - Capital Market Ratios

Financial Ratios - Annual Ratios

Performance Chart

Financial Performance

Financial Ratios - Interim Ratios

Financial Ratios - Ratio Charts

Section 4 – Company’s Lifesciences Financial Deals and Alliances

Endologix Inc, Medical Equipment, Deals By Year, 2013 to YTD 2019

Endologix Inc, Medical Equipment, Deals By Type, 2013 to YTD 2019

Endologix Inc, Recent Deals Summary

Section 5 – Company’s Recent Developments

May 02, 2019: Endologix reports first quarter 2019 financial results

Feb 25, 2019: Endologix announces fourth quarter and fiscal year 2018 financial results

Jan 10, 2019: Endologix names John D. Zehren as Chief Commercial Officer

Jan 07, 2019: Endologix Announces Fourth Quarter and Full-Year 2018 Preliminary Financial Results and Provides 2019 Financial Guidance

Nov 15, 2018: Endologix honors innovators of aortic therapy at VEITHsymposium

Nov 01, 2018: Endologix reports third quarter 2018 financial results

Oct 02, 2018: Endologix Announces Third Quarter Preliminary Revenue Results and Raises Low End of 2018 Revenue Guidance Range

Aug 15, 2018: Endologix appoints Jeffrey S. Brown as Chief Operations Officer

Aug 09, 2018: Endologix reports second quarter 2018 financial results

Jun 25, 2018: Endologix Names Jeffry Fecho As Chief Quality Officer

Section 6 – Appendix

Methodology

Ratio Definitions

About GlobalData

Contact Us

Disclaimer

List of Tables

List of Tables

Endologix Inc, Key Facts

Endologix Inc, Key Employees

Endologix Inc, Key Employee Biographies

Endologix Inc, Major Products and Services

Endologix Inc, History ...

List of Tables

Endologix Inc, Key Facts

Endologix Inc, Key Employees

Endologix Inc, Key Employee Biographies

Endologix Inc, Major Products and Services

Endologix Inc, History

Endologix Inc, Subsidiaries

Endologix Inc, Key Competitors

Endologix Inc, Ratios based on current share price

Endologix Inc, Annual Ratios

Endologix Inc, Annual Ratios (Cont...1)

Endologix Inc, Interim Ratios

Endologix Inc, Medical Equipment, Deals By Year, 2013 to YTD 2019

Endologix Inc, Medical Equipment, Deals By Type, 2013 to YTD 2019

Endologix Inc, Recent Deals Summary

Currency Codes

Capital Market Ratios

Equity Ratios

Profitability Ratios

Cost Ratios

Liquidity Ratios

Leverage Ratios

Efficiency Ratios

List of Figures

List of Figures

Endologix Inc, Performance Chart (2014 - 2018)

Endologix Inc, Ratio Charts

Endologix Inc, Medical Equipment, Deals By Year, 2013 to YTD 2019

Endologix ...

List of Figures

Endologix Inc, Performance Chart (2014 - 2018)

Endologix Inc, Ratio Charts

Endologix Inc, Medical Equipment, Deals By Year, 2013 to YTD 2019

Endologix Inc, Medical Equipment, Deals by Type, 2013 to YTD 2019

    Pricing

Discounts available for multiple report purchases.

reportstore@marketline.com
+44 (0) 161 359 5817

Saved reports